Chemours vs Olin
Olin reported revenue of $6.8 billion in fiscal 2025, 1.2 times Chemours' $5.8 billion in fiscal 2025. Chemours' revenue grew 0.5% in its latest year, and Olin's grew 3.7%. Free cash flow was $51 million at Chemours and $248 million at Olin.
Side by side
| Chemours | Olin | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $5.8B | $6.8B |
| Revenue growth | 0.5% | 3.7% |
| Revenue growth a year, last 5 years | 3.2% | 3.3% |
| Gross margin | 15.5% | 7.4% |
| Operating margin | — | 0.1% |
| Net margin | −6.7% | −1.5% |
| Free cash flow | $51M | $248M |
| Free cash flow margin | 0.9% | 3.7% |
| Return on capital | −0.2% | 0.1% |
| Net debt to EBITDA | 10.6x | 5.1x |
| Dividends and buybacks | $78M | $142M |
| Change in diluted share count | 0.0% | −4.1% |
| Last close | $12.87 | $15.94 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | bought $488,650, sold $0 | sold $2.5 million |
| Piotroski F-score | 4 of 9 | 4 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
ChemoursOlin
Operating margin
Percent of revenue
ChemoursOlin
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
ChemoursOlin